Advertisement

Topics

NICE turns down Darzalex combo for pre-treated multiple myeloma

19:40 EDT 12 Jul 2018 | PharmaTimes

Janssen says it is disappointed that NHS cost regulators are not backing NHS use of Darzalez (daratumumab) plus bortezomib and dexamethasone (DBd) for previously treated multiple myeloma in adults.

Original Article: NICE turns down Darzalex combo for pre-treated multiple myeloma

NEXT ARTICLE

More From BioPortfolio on "NICE turns down Darzalex combo for pre-treated multiple myeloma"

Advertisement
Quick Search
Advertisement
Advertisement